APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Spray Flu Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nasal Spray Flu Vaccines Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchNasal Spray Flu Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Spray Flu Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Nasal Spray Flu Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Spray Flu Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Spray Flu Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nasal Spray Flu Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nasal Spray Flu Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nasal Spray Flu Vaccines market include Abbott, GlaxoSmithKline, AstraZeneca, Serum Institute of India, Sanofi Pasteur and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nasal Spray Flu Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nasal Spray Flu Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nasal Spray Flu Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nasal Spray Flu Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Nasal Spray Flu Vaccines Segment by Company

Abbott

GlaxoSmithKline

AstraZeneca

Serum Institute of India

Sanofi Pasteur

CSL

Nasal Spray Flu Vaccines Segment by Type

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

Nasal Spray Flu Vaccines Segment by Application

Clinic

Hospital

Public Health Agency

Other

Nasal Spray Flu Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nasal Spray Flu Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nasal Spray Flu Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nasal Spray Flu Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Nasal Spray Flu Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Spray Flu Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Spray Flu Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Spray Flu Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nasal Spray Flu Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nasal Spray Flu Vaccines industry.

Chapter 3: Detailed analysis of Nasal Spray Flu Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nasal Spray Flu Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nasal Spray Flu Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nasal Spray Flu Vaccines Industry Trends Table 2. Nasal Spray Flu Vaccines Industry Drivers Table 3. Nasal Spray Flu Vaccines Industry Opportunities and Challenges Table 4. Nasal Spray Flu Vaccines Industry Restraints Table 5. Global Nasal Spray Flu Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nasal Spray Flu Vaccines Revenue Share by Company (2021-2026) Table 7. Global Nasal Spray Flu Vaccines Sales Volume by Company (k doses) & (2021-2026) Table 8. Global Nasal Spray Flu Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Nasal Spray Flu Vaccines Average Price (US$/dose) of Company (2021-2026) Table 10. Global Nasal Spray Flu Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nasal Spray Flu Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Nasal Spray Flu Vaccines Company, Product Type & Application Table 13. Global Nasal Spray Flu Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nasal Spray Flu Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Trivalent Flu Vaccine Table 18. Significant Companies of Quadrivalent Flu Vaccine Table 19. Global Nasal Spray Flu Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k doses) Table 20. Global Nasal Spray Flu Vaccines Sales Volume by Type (2021-2026) & (k doses) Table 21. Global Nasal Spray Flu Vaccines Sales Volume by Type (2027-2032) & (k doses) Table 22. Global Nasal Spray Flu Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Nasal Spray Flu Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Nasal Spray Flu Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nasal Spray Flu Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nasal Spray Flu Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nasal Spray Flu Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Nasal Spray Flu Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Public Health Agency Table 32. Significant Companies of Other Table 33. Global Nasal Spray Flu Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k doses) Table 34. Global Nasal Spray Flu Vaccines Sales Volume by Application (2021-2026) & (k doses) Table 35. Global Nasal Spray Flu Vaccines Sales Volume by Application (2027-2032) & (k doses) Table 36. Global Nasal Spray Flu Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Nasal Spray Flu Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Nasal Spray Flu Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nasal Spray Flu Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Nasal Spray Flu Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Nasal Spray Flu Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Nasal Spray Flu Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Nasal Spray Flu Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 44. Global Nasal Spray Flu Vaccines Sales by Region (2021-2026) & (k doses) Table 45. Global Nasal Spray Flu Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Nasal Spray Flu Vaccines Sales by Region (2027-2032) & (k doses) Table 47. Global Nasal Spray Flu Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Nasal Spray Flu Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Nasal Spray Flu Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Nasal Spray Flu Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Nasal Spray Flu Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Nasal Spray Flu Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Nasal Spray Flu Vaccines Market Average Price (US$/dose) by Region (2021-2026) Table 54. Global Nasal Spray Flu Vaccines Market Average Price (US$/dose) by Region (2027-2032) Table 55. Global Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Table 56. Global Nasal Spray Flu Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 58. Global Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Nasal Spray Flu Vaccines Sales by Country (2027-2032) & (k doses) Table 60. Global Nasal Spray Flu Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Nasal Spray Flu Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Nasal Spray Flu Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Nasal Spray Flu Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Nasal Spray Flu Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 68. Abbott Nasal Spray Flu Vaccines Product Portfolio Table 69. Abbott Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 78. AstraZeneca Nasal Spray Flu Vaccines Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Serum Institute of India Company Information Table 81. Serum Institute of India Business Overview Table 82. Serum Institute of India Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 83. Serum Institute of India Nasal Spray Flu Vaccines Product Portfolio Table 84. Serum Institute of India Recent Development Table 85. Sanofi Pasteur Company Information Table 86. Sanofi Pasteur Business Overview Table 87. Sanofi Pasteur Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 88. Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolio Table 89. Sanofi Pasteur Recent Development Table 90. CSL Company Information Table 91. CSL Business Overview Table 92. CSL Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 93. CSL Nasal Spray Flu Vaccines Product Portfolio Table 94. CSL Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Nasal Spray Flu Vaccines Distributors List Table 98. Nasal Spray Flu Vaccines Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Nasal Spray Flu Vaccines Product Image Figure 2. Global Nasal Spray Flu Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nasal Spray Flu Vaccines Sales (2021-2032) & (k doses) Figure 5. Global Nasal Spray Flu Vaccines Sales Average Price (US$/dose) & (2021-2032) Figure 6. Global Nasal Spray Flu Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Trivalent Flu Vaccine Image Figure 10. Quadrivalent Flu Vaccine Image Figure 11. Global Nasal Spray Flu Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k doses) Figure 12. Global Nasal Spray Flu Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nasal Spray Flu Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Nasal Spray Flu Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nasal Spray Flu Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nasal Spray Flu Vaccines Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Public Health Agency Image Figure 20. Other Image Figure 21. Global Nasal Spray Flu Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k doses) Figure 22. Global Nasal Spray Flu Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Nasal Spray Flu Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Nasal Spray Flu Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Nasal Spray Flu Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Nasal Spray Flu Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Nasal Spray Flu Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 28. Global Nasal Spray Flu Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Nasal Spray Flu Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Nasal Spray Flu Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Nasal Spray Flu Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Nasal Spray Flu Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Nasal Spray Flu Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Nasal Spray Flu Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Nasal Spray Flu Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Nasal Spray Flu Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Nasal Spray Flu Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Nasal Spray Flu Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine
Applications
  • Clinic
  • Hospital
  • Public Health Agency
  • Other
Companies covered
  • Abbott
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • Sanofi Pasteur
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nasal Spray Flu Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Nasal Spray Flu Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Nasal Spray Flu Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nasal Spray Flu Vaccines Market Dynamics
  1. 2.1 Nasal Spray Flu Vaccines Industry Trends
  2. 2.2 Nasal Spray Flu Vaccines Industry Drivers
  3. 2.3 Nasal Spray Flu Vaccines Industry Opportunities and Challenges
  4. 2.4 Nasal Spray Flu Vaccines Industry Restraints
3 Nasal Spray Flu Vaccines Market by Company
  1. 3.1 Global Nasal Spray Flu Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Nasal Spray Flu Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Nasal Spray Flu Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Nasal Spray Flu Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Nasal Spray Flu Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Nasal Spray Flu Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Nasal Spray Flu Vaccines Company Product Type and Application
  8. 3.8 Global Nasal Spray Flu Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nasal Spray Flu Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nasal Spray Flu Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nasal Spray Flu Vaccines Market by Type
  1. 4.1 Nasal Spray Flu Vaccines Type Introduction
  2. 4.1.1 Trivalent Flu Vaccine
  3. 4.1.2 Quadrivalent Flu Vaccine
  4. 4.2 Global Nasal Spray Flu Vaccines Sales Volume by Type
  5. 4.2.1 Global Nasal Spray Flu Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nasal Spray Flu Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nasal Spray Flu Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nasal Spray Flu Vaccines Sales Value by Type
  9. 4.3.1 Global Nasal Spray Flu Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nasal Spray Flu Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nasal Spray Flu Vaccines Sales Value Share by Type (2021-2032)
5 Nasal Spray Flu Vaccines Market by Application
  1. 5.1 Nasal Spray Flu Vaccines Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Public Health Agency
  5. 5.1.4 Other
  6. 5.2 Global Nasal Spray Flu Vaccines Sales Volume by Application
  7. 5.2.1 Global Nasal Spray Flu Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nasal Spray Flu Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Nasal Spray Flu Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Nasal Spray Flu Vaccines Sales Value by Application
  11. 5.3.1 Global Nasal Spray Flu Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nasal Spray Flu Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Nasal Spray Flu Vaccines Sales Value Share by Application (2021-2032)
6 Nasal Spray Flu Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Nasal Spray Flu Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nasal Spray Flu Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Nasal Spray Flu Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Nasal Spray Flu Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Nasal Spray Flu Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nasal Spray Flu Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nasal Spray Flu Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nasal Spray Flu Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Nasal Spray Flu Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nasal Spray Flu Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Nasal Spray Flu Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nasal Spray Flu Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Nasal Spray Flu Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nasal Spray Flu Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nasal Spray Flu Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nasal Spray Flu Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Nasal Spray Flu Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nasal Spray Flu Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nasal Spray Flu Vaccines Sales Value Share by Country, 2025 VS 2032
7 Nasal Spray Flu Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nasal Spray Flu Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nasal Spray Flu Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Nasal Spray Flu Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Nasal Spray Flu Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nasal Spray Flu Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nasal Spray Flu Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nasal Spray Flu Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nasal Spray Flu Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nasal Spray Flu Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Nasal Spray Flu Vaccines Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Nasal Spray Flu Vaccines Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India Nasal Spray Flu Vaccines Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Sanofi Pasteur
  26. 8.5.1 Sanofi Pasteur Company Information
  27. 8.5.2 Sanofi Pasteur Business Overview
  28. 8.5.3 Sanofi Pasteur Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolio
  30. 8.5.5 Sanofi Pasteur Recent Developments
  31. 8.6 CSL
  32. 8.6.1 CSL Company Information
  33. 8.6.2 CSL Business Overview
  34. 8.6.3 CSL Nasal Spray Flu Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CSL Nasal Spray Flu Vaccines Product Portfolio
  36. 8.6.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nasal Spray Flu Vaccines Value Chain Analysis
  2. 9.1.1 Nasal Spray Flu Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nasal Spray Flu Vaccines Sales Mode & Process
  6. 9.2 Nasal Spray Flu Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nasal Spray Flu Vaccines Distributors
  9. 9.2.3 Nasal Spray Flu Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst